TheodoreEOkersonIIMDFACE, FACP, FTOS

PubMed

• Control of type 2 diabetes after 1 year of laparoscopic adjustable gastric banding in the helping evaluate reduction in obesity (HERO) study.
  Edelman, S.,Ng-Mak, D. S.,Fusco, M.,Ashton, D.,Okerson, T.,Liu, Q.,Jin, J.,Dixon, J. B.> ;Diabetes Obes Metab. 2014 May 16
• Weight loss through adjustable gastric banding and improvement in daytime sleepiness: 2 year interim results of APEX study.
  Fusco M James S Cornell C Okerson T> ;Curr Med Res Opin. 2014 Jan 17
• Efficacy and safety of the adjustable gastric band - pooled interim analysis of the APEX and HERO studies at 48 weeks.
  Ponce J Taheri S Lusco V Cornell C Ng-Mak DS Shi R Okerson T> ;Curr Med Res Opin. 2014 Jan 16
• Prevalence of comorbidities and baseline characteristics of LAP-BAND AP(R) subjects in the Helping Evaluate Reduction in Obesity (HERO) study.
  Dreyer N Dixon JB Okerson T Finkelstein EA Globe D> ;PLoS One. 2013
• Reduction in Framingham risk of cardiovascular disease in obese patients undergoing laparoscopic adjustable gastric banding.
  Largent JA Vasey J Bessonova L Okerson T Wong ND> ;Adv Ther. 2013 Jul
• Effect of early weight loss on type 2 diabetes mellitus after 2 years of gastric banding.
  Edelman S Bhoyrul S Billy H Cornell C Okerson T> ;Postgrad Med. 2012 Nov
• Interim results at 48 weeks of LAP-BAND AP experience (APEX) study: prospective, multicenter, open-label longitudinal patient observational study.
  Cywes R Bhoyrul S Billy H Ponce J Okerson T Oefelein MG> ;Surg Obes Relat Dis. 2012 Nov-Dec
• Safety and efficacy of the LAP-BAND AP(R) adjustable gastric band in the treatment of obesity: results at 2 years.
  Shayani V Voellinger D Liu C Cornell C Okerson T> ;Postgrad Med. 2012 Jul
• 92 citations
  The cardiovascular effects of GLP-1 receptor agonists.
  Theodore Okerson, Robert J. Chilton> ;Cardiovascular Therapeutics. 2012 Jun 1
• Effect of adjustable gastric banding on changes in gastroesophageal reflux disease (GERD) and quality of life.
  Woodman G Cywes R Billy H Montgomery K Cornell C Okerson T> ;Curr Med Res Opin. 2012 Apr
• Risk of lymphoma in women with breast implants: analysis of clinical studies.
  Largent J Oefelein M Kaplan HM Okerson T Boyle P> ;Eur J Cancer Prev. 2012 May
• To band or bypass.
  Oefelein MG Okerson T> ;Arch Surg. 2011 Sep
• Effects of exenatide on systolic blood pressure in subjects with type 2 diabetes.
  Okerson T Yan P Stonehouse A Brodows R> ;Am J Hypertens. 2010 Mar
• Effects of exenatide on diabetes, obesity, cardiovascular risk factors, and hepatic biomarkers in patients with type 2 diabetes.
  Nielsen LL Okerson T Holcombe J Hoogwerf B> ;J Diabetes Sci Technol. 2008 Mar
• Effects of exenatide versus sitagliptin on postprandial glucose, insulin and glucagon secretion, gastric emptying, and caloric intake: a randomized, cross-over study.
  DeFronzo RA Okerson T Viswanathan P Guan X Holcombe JH MacConell L> ;Curr Med Res Opin. 2008 Oct
• Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-control...
  Moretto TJ Milton DR Ridge TD Macconell LA Okerson T Wolka AM Brodows RG> ;Clin Ther. 2008 Aug
• Emerging incretin based therapies for type 2 diabetes: incretin mimetics and DPP-4 inhibitors.
  Stonehouse A Okerson T Kendall D Maggs D> ;Curr Diabetes Rev. 2008 May
• Join now to see all

Journal Articles

• "Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low-Density Lipoprotein Cholesterol in Atherosclerotic Cardiovascular Disease Pat...  
  Okerson T, Patel J, DiMario S, Burton T, Seare J, Harrison DJ, J Am Heart Assoc, 1/1/2017
• "Quality of Life after Laparoscopic Adjustable Gastric Banding (LAP-BAND): APEX Interim 3-Year Analysis"  
  Billy HT, Sarwer DB, Ponce J, Ng-Mak D, Shi R, Cornell C, Okerson T, Postgraduate Medicine, 1/1/2014
• "Control of Type 2 Diabetes after 1 Year of Laparoscopic Adjustable Gastric Banding in the Helping Evaluate Reduction in Obesity (HERO) Study"  
  Edelman S, Ng-Mak DS, Fusco M, Ashton D, Okerson T, Liu Q, Jin J, Dixon J, Diabetes, Obesity and Metabolism, 1/1/2014
• "Weight Loss through Adjustable Gastric Banding and Improvement in Daytime Sleepiness: 2 Year Interim Results of the APEX Study"  
  Fusco M, James S, Cornell C, Okerson T, Current Medical Research and Opinion, 1/1/2014
• "Efficacy and Safety of the Adjustable Gastric Band-Pooled Interim Analysis of the APEX and HERO studies at 48 weeks"  
  Ponce J, Taheri S, Lusco V, Cornell C, Ng-Mak D, Okerson T, Current Medical Research and Opinion, 1/1/2014
• "Reduction in Framingham Risk of Cardiovascular Disease in Obese Patients Undergoing Laparoscopic Adjustable Gastric Banding"  
  Largent J, Vasey J, Bessanova L, Okerson T, Wong N, Advances in Therapy, 1/1/2013
• "Effect of Early Weight Loss on Type 2 Diabetes Mellitus after 2 Years of Gastric Banding"  
  Edelman S, Bhoyrul S, Billy H, Cornell C, Okerson T, Postgraduate Medicine, 1/1/2012
• "Safety and Efficacy of the LAP-BAND AP� Adjustable Gastric Band in the Treatment of Obesity: Results at 2 Years"  
  Shayani V, Voellinger D, Liu C, Cornell C, Okerson T, Postgraduate Medicine, 1/1/2012
• "Effect of Adjustable Gastric Banding on Changes in Gastroesophageal Reflux Disease (GERD) and Quality of Life"  
  Woodman G, Cywes R, Billy H, Montgomery K, Cornell C, Okerson T, Current Medical Research & Opinion, 1/1/2012
• "Risk of Lymphoma in Women with Breast Implants: Analysis of Clinical Studies"  
  Largent J, Oefelein M, Kaplan MK, Okerson T, Boyle P, European Journal of Cancer Prevention, 1/1/2012
• "The Cardiovascular Effects of GLP-1 Receptor Agonists"  
  Okerson T, Chilton R, Cardiovascular Therapeutics, 1/1/2012
• "Effects of Exenatide on Systolic Blood Pressure in Subjects with Type 2 Diabetes"  
  Okerson T, Yan P, Stonehouse A, Brodows R, American Journal of Hypertension, 1/1/2010
• "The Case for Exenatide as a Treatment Option before Insulin in Patients with Type 2 Diabetes"  
  Henry RR, Walsh B, Holcombe JH, Okerson T, Practical Diabetology, 1/1/2008
• "Effects of Exenatide versus Sitagliptin on Postprandial Glucose, Insulin and Glucagon Secretion, Gastric Emptying, and Caloric Intake: a Randomized, Cross-over Study"  
  DeFronzo RA, Okerson T, Viswanathan P, Guan X, Holcombe JH, MacConell L, Current Medical Research and Opinion, 1/1/2008
• "Efficacy and Tolerability of Exenatide Monotherapy Over 24 Weeks in Antidiabetic, Drug-Na�ve Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Contro...  
  Moretto T, Milton D, Ridge T, MacConell L, Okerson T, Wolka A, Brodows R, Current Therapeutics, 1/1/2008
• "Emerging Incretin-Based Therapies for Type 2 Diabetes: Incretin Mimetics and DPP-4 Inhibitors"  
  Stonehouse A, Okerson T, Kendall D, Maggs D, Current Diabetes Reviews, 1/1/2008
• "Effects of Exenatide on Diabetes, Obesity, Cardiovascular Risk Factors, and Hepatic Biomarkers in Patients with Type 2 Diabetes"  
  Nielsen L, Okerson T, Holcombe J, Hoogwerf B, Journal of Diabetes Science and Technology, 1/1/2008
• Join now to see all

Abstracts/Posters

• "Changes in Lipid-Lowering Therapy Following a Cardiovascular Event in Patients with Diabetes Mellitus"
  Okerson T, Cohen S, Killian J, Weston S, Monda K, Chamberlain A, 53rd Annual Meeting of the European Association for the Study of Diabetes, Lisbon, Portugal, 1/1/2017
• "Comparison of Lipid-Lowering Treatment in Patients with Diabetes and/or Cardiovascular Disease"
  Cohen SS, Chamberlain AM, Killian JM, Monda KL, Weston MS, Okerson T, American Diabetes Association 77th Scientific Sessions, San Diego, CA, 1/1/2017
• "Lipid-lowering Therapy Prescription Patterns and Predictors of High Intensity Statin Prescriptions in Patients With Diabetes or Atherosclerotic Cardiovascular Disease."
  Chamberlain AM, Cohen SS, Killian JM, Monda KL, Hedgeman EO, Weston SA, Okerson T, Circulation, Epi/Lifestyle 2017 Scientific Sessions, Portland, OR, 1/1/2017
• "Effect of 2013 ACC/AHA Blood Cholesterol Guidelines on Statin Treatment Patterns and Low Density Lipoprotein Cholesterol (LDL-C) Levels in Patients with Atherosclerot...
  Okerson T, Patel J, DiMario S, et al, 2016 American Heart Association Scientific Sessions, New Orleans, LA, 1/1/2016
• "Changes in Hypertension Control in African-Americans Compared to Other Ethnicities 3.5 Years after Adjustable Gastric Banding for Morbid Obesity."
  Okerson T, Shi R, American Society of Hypertension Annual Meeting, San Francisco, CA, 1/1/2013
• "Durability of Diabetes Remission after Adjustable Gastric Banding."
  Okerson T, Shi R, American Association of Clinical Endocrinologists Annual Meeting, Phoenix, AZ, 1/1/2013
• "Effect of Early Weight Loss on Type 2 Diabetes through @2 Years after Laparoscopic Gastric Banding."
  Okerson T, Bhoyrul S, Cornell C, Canadian Diabetes Association Annual Meeting, Vancouver, British Columbia, 1/1/2012
• "Effect of Surgically-Induced Weight Loss in African-Americans with Hypertension."
  Bhoyrul S, Woodman G, Cornell C, Okerson T, Canadian Diabetes Association Annual Meeting, Vancouver, British Columbia, 1/1/2012
• "One Year Change in Metabolic Syndrome Components in the Helping Evaluate Reduction in Obesity (HERO) Study."
  Dixon J, Okerson T, Burk C, Rui S, Ng-Mak D, Globe D, Dreyer N, Canadian Diabetes Association Annual Meeting, Vancouver, British Columbia, 1/1/2012
• "Effectiveness of Adjustable Gastric Banding Based on Baseline BMI."
  Watkins B, Cornell C, Okerson T, The Obesity Society 30th Annual Scientific Meeting, San Antonio, TX, 1/1/2012
• "One Year Change in Metabolic Syndrome Components in the Helping Evaluate Reduction in Obesity (HERO) Study."
  Dixon J, Okerson T, Burk C, Rui S, Ng-Mak D, Globe D, Dreyer N, The Obesity Society 30th Annual Scientific Meeting, San Antonio, TX, 1/1/2012
• "Adjustable Gastric Banding Improves Obesity and Weight-Loss Quality of Life (OWLQOL) Measures over 3 years: Interim Results of the APEX Study"
  Ponce J, Billy H, Smith A, Curry T, Cornell C, Okerson T, Obesity Surgery, XVII World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), India, 1/1/2012
• "Effectiveness of Adjustable Gastric Banding based on Baseline BMI"
  Watkins B, Cornell C, Okerson T, Obesity Surgery, XVII World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), India, 1/1/2012
• "Number of Visits (But Not Adjustments) is Related to Weight Loss in Gastric Banding Patients"
  Watkins B, Cornell C, Okerson T, Obesity Surgery, XVII World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), India, 1/1/2012
• "Effect of Surgically-Induced Weight Loss in Blacks with Hypertension"
  Woodman G, Cywes R, Dixon J, Cornell C, Okerson T, Obesity Surgery, XVII World Congress of the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO), India, 1/1/2012
• "Timing of Adjustable Gastric Banding and "Remission" or Improvement of Type 2 Diabetes and Associated Risk Factors."
  Billy H, Bhoyrul S, Okerson T, Cornell C, Diabetes, 1/1/2012
• "Helping Evaluate Reduction in Obesity: Characterizing Patients who Choose LAP-BAND in the HERO Observational Study."
  Dixon J, Finkelstein E, Dreyer N, Menon V, Globe D, Okerson T, 29th Annual Meeting of American Society for Metabolic and Bariatric Surgery, San Diego, CA, 1/1/2012
• "Adjustable Gastric Banding Improves Obesity and Weight-Loss Quality of Life (OWLQOL) Measures over 3 years: Interim Results of the APEX Study."
  Ponce J, Billy H, Smith A, Curry T, Cornell C, Okerson T, 29th Annual Meeting of American Society for Metabolic and Bariatric Surgery, San Diego, CA, 1/1/2012
• "Effects of Adjustable Gastric Banding After 2 � Years-An Interim Report from the APEX Study."
  Woodman G, Cywes R, Liu C, Bhoyrul S, Cornell C, Okerson T, 29th Annual Meeting of American Society for Metabolic and Bariatric Surgery, San Diego, CA, 1/1/2012
• "One Year Change in Diabetes Remission in the Helping Evaluate Reduction in Obesity (HERO) study."
  Torre M, Dixon J, Finkelstein EK, Okerson T, Shi R, Ng-Mak D, Globe D, Diabetes, 1/1/2012
• "Effect of Surgically-Induced Weight Loss in Blacks with Hypertension."
  Woodman G, Cywes R, Dixon J, Cornell C, Okerson T, European Congress on Obesity, Lyon, France, 1/1/2012
• "Effects of Adjustable Gastric Banding After 2 � Years-An Interim Report from the APEX Study."
  Woodman G, Cywes R, Liu C, Bhoyrul S, Cornell C, Okerson T, European Congress on Obesity, Lyon, France, 1/1/2012
• "Adjustable Gastric Banding Improves Obesity and Weight-Loss Quality of Life (OWLQOL) Measures over 3 years: Interim Results of the APEX Study."
  Ponce J, Billy H, Smith A, Curry T, Cornell C, Okerson T, European Congress on Obesity, Lyon, France, 1/1/2012
• "Assessing Real-world European Patient Profiles in the Helping Evaluate Reduction in Obesity (HERO) Study."
  Dixon J, Dreyer N, Finkelstein EA, Su Z, Globe D, Okerson T, EuroPRevent Congress, Dublin, Ireland, 1/1/2012
• "Effect of Surgically-induced Weight Loss in African Americans with Hypertension."
  Woodman G, Cywes R, Dixon J, Cornell C, Okerson T, Journal of Clinical Hypertension, 1/1/2012
• Join now to see all

Lectures

• "Early Intervention with Bariatric Surgery in Type 2 Diabetes" 
  Saalfelden, Austria - 1/11/2012
• "GLP-1 and Bariatric Surgery: Updates, Synergies and Potential CV Benefits" 
  Saalfelden, Austria - 1/11/2012
• "Changes in Body Composition following Gastric Bypass or Gastric Banding" 
  Philadelphia, PA - 1/1/2012
• "Effect of Early Weight Loss on Type 2 Diabetes through Surgical Intervention 2 Years after Gastric Banding" 
  Philadelphia, PA - 1/1/2012
• "Changes in Hypertension Status and Medication Utilization in the Helping Evaluate Reduction in Obesity (HERO) Study." 
  New York, NY - 1/1/2012
• "Patient Reported Resolution of Gastroesophageal Reflux Disease (GERD) after Adjustable Gastric Banding-1 Year Interim Results of the LAP-BAND AP� Experience (APEX) St... 
  San Antonio, TX - 1/1/2011
• "ALCL and Breast Implants" 
  Portland, OR - 1/1/2010
• "Exenatide Improved Acute Phase Insulin Response to a Meal in Patients with Type 2 Diabetes" 
  San Francisco, CA - 1/1/2008
• "Exenatide Treatment for 2.5 Years was Associated with Improved Glycemic Control and Reduced Weight Irrespective of Baseline Duration of Type 2 Diabetes" 
  1/1/2007
• "Diabetes Update" 
  San Diego, CA - 1/1/2006
• "Update on Incretins" 
  Camp Pendleton, CA - 1/1/2006
• "Importance of Tight Blood Pressure Control" 
  Nashville, TN - 1/1/2006
• "Patient-Oriented Research I" 
  1/1/2006
• "Designing a Clinical Research Protocol" 
  1/1/2006
• "The Role of Inflammation in Atherogenesis" 
  1/1/2006
• "Novel Potential New Therapies for Type 2 Diabetes Mellitus: An Update on Incretins" 
  San Diego - 1/1/2005
• "Incretins and Gut Hormones" 
  1/20/2004
• "Hypertension-Pathophysiology and Treatment" 
  Long Beach, CA - 1/19/2004
• "Hypertension" 
  1/16/2004
• "Congestive Heart Failure: A Clinician's Perspective" 
  1/1/2001
• "Calcium, Calcium Channel Blockers and ACLS" 
  UCI (University of California, Irvine) Medical Center - 1/18/1987
• "Medical Management of Pregnant Patients" 
  UCI (University of California, Irvine) Medical Center - 1/28/1986
• "Carcinoid Syndrome" 
  UCI (University of California, Irvine) Medical Center - 1/4/1986
• Join now to see all